 |
The Organizing Committee is pleased to present an archived webcast of selected
lectures (view
program.pdf) from its scientific symposium celebrating the 10th
Anniversary of the Department of Pain Medicine and Palliative Care (DPMPC) at
Beth Israel Medical Center. The meeting took place at the New York Marriott
Marquis on Saturday, March 15, 2008 in New York City, New York.
In the decade since the DPMPC was founded as the nation's first academic department
devoted to the two specialties of pain medicine and palliative care, great strides
have been made in both disciplines.
This symposium highlights some of the key advances in pain neurobiology, analgesic
pharmacology, quality-of-life concerns in the medically ill, and emerging systems
of care. This activity will help you to
- Evaluate the ongoing controversies in chronic pain management and palliative
care in order to provide the best care for your patients.
- Review the risks and benefits of opioid therapy for chronic malignant
and nonmalignant pain, including opioid use in breakthrough pain, in order
to better explain opioid titration and rotation, and common side effects,
to your patients.
- Examine your use of opioids to manage pain in patients with histories of
substance abuse or addiction, and assess whether you have been using pain
medications optimally.
- Review the latest interventional strategies for pain management, and recognize
when these strategies should be implemented.
|
Webcast
Agenda:
- Ricardo Cruciani, MD, PhD
- Russell K. Portenoy, MD
- Edwin Salsitz, MD
- Case Discussion
- Kathleen M. Foley, MD
- Subhash Jain, MD
- Richard Payne, MD
|
|
|
Target Audience: This course is intended for pain specialists
(anesthesiologists and neurologists), palliative care specialists, nurse practitioners,
registered nurses, pharmacists, social workers, and medical students.
Faculty Disclosure: Please view this
faculty disclosure (.pdf) before registering for the webcast.
ACKNOWLEDGMENT: The Department of Pain Medicine and Palliative
Care gratefully acknowledges the following companies for their unrestricted
educational grants in support of this activity:
- Abbott Laboratories
- Archimedes Pharma Ltd.
- Baxter Healthcare Corporation
- Cephalon, Inc.
- Endo Pharmaceuticals
- GW Pharmaceuticals plc
- King Pharmaceuticals
- Wyeth Pharmaceuticals
- Biovail Corporation
- Elan Pharmaceuticals, Inc.
- Purdue Pharma LP
- Medtronic, Inc.
For more information about the entire program, see this brochure (.pdf). If you need technical assistance, please email: stoppain@chpnet.org.
You will need to have either Windows Media Player or RealPlayer/RealOne Player installed on your computer to access these lectures.
Slides accompanying these audio lectures are printable, clicking on the "Presentation Links" option, using Adobe Acrobat Reader. Please install these free plug-ins before entering
this module.
|
|
|